- Share Prices
Shield Therapeutics PLC (STX)
2.50p-0.03 (-0.99%)12 Jun 2025, 16:35
Shield Therapeutics PLC Market & Company News
| 22.05.2025 17:06 | STX | Result of AGM | RNS |
| 24.04.2025 07:06 | STX | Audited results for the year ended 31 Dec 2024 | RNS |
| 22.04.2025 11:02 | STX | Shield Therapeutics inks licencing agreement for iron deficiency drug | Alliance |
| 22.04.2025 07:01 | STX | Licence Agreement in Japan for ACCRUFeR® | RNS |
| 17.04.2025 21:57 | IOF, REE, HAYD | TRADING UPDATES: BP Marsh's new buyback; Iofina lowers production view | Alliance |
| 17.04.2025 11:23 | STX | Q1 2025 Trading Update | RNS |
| 11.03.2025 07:00 | STX | ACCRUFeR® launched in Canada | RNS |
| 13.02.2025 16:15 | STX | PDMR Transaction Notification | RNS |
| 13.02.2025 07:00 | STX | Grant of Share Options | RNS |
| 05.02.2025 16:30 | STX | Shield Therapeutics shares surge as revenue up on prescription growth | Alliance |
| 05.02.2025 07:00 | STX | Unaudited full year trading update | RNS |
| 28.01.2025 13:43 | AZN, API, FCSS | EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO | Alliance |
| 27.01.2025 07:00 | STX | Anders Lundstrom appointed CEO | RNS |
| 24.12.2024 11:25 | STX | Result of General Meeting & Total Voting Rights | RNS |
| 23.12.2024 07:00 | STX | Results of RetailBook Offer | RNS |
| 17.12.2024 13:37 | STX | UK shareholder meetings calendar - next 7 days | Alliance |
| 06.12.2024 14:35 | STX | Shield Therapeutics to raise USD10.0 million via AOP subscription | Alliance |
| 06.12.2024 11:31 | STX | RetailBook Offer | RNS |
| 06.12.2024 11:30 | STX | Subscription by AOP Health to raise US$10 million | RNS |
| 21.11.2024 14:22 | STX | Shield Therapeutics shares up on strong October sales | Alliance |
| 21.11.2024 11:15 | STX | Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven | EQS |
| 21.11.2024 07:00 | STX | Business Update | RNS |
| 11.11.2024 14:00 | STX | Hardman & Co Video Event: Shield Therapeutics (STX) Investor Forum | EQS |
| 29.10.2024 14:34 | STX | Shield Therapeutics shares slide as it expands financing arrangement | Alliance |
| 29.10.2024 07:00 | STX | Q3 Trading Update | RNS |
| 25.09.2024 07:00 | STX | Results from Phase 3 paediatric study | RNS |
| 11.09.2024 12:25 | STX | Hardman & Co Research on Shield Therapeutics (STX): Focusing on successful execution | EQS |
| 04.09.2024 11:39 | STX | Shield Therapeutics revenue triples, but cost rises widen annual loss | Alliance |
| 04.09.2024 11:06 | STX, ROCK | AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade | Alliance |
| 04.09.2024 07:00 | STX | Interim results | RNS |
| 28.08.2024 15:52 | STX, POLX, HFG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.08.2024 19:34 | MLVN, TIME, GDP | TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up | Alliance |
| 27.08.2024 07:00 | STX | ACCRUFeR® Approved by Health Canada | RNS |
| 14.08.2024 07:00 | STX | Notice of interim results | RNS |
